Cargando…
Ex vivo Bone Models and Their Potential in Preclinical Evaluation
PURPOSE OF REVIEW: Novel therapies for damaged and diseased bone are being developed in a preclinical testing process consisting of in vitro cell experiments followed by in vivo animal studies. The in vitro results are often not representative of the results observed in vivo. This could be caused by...
Autores principales: | Cramer, E. E. A., Ito, K., Hofmann, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935733/ https://www.ncbi.nlm.nih.gov/pubmed/33428030 http://dx.doi.org/10.1007/s11914-020-00649-5 |
Ejemplares similares
-
Osteoblast-Chondrocyte Interactions in Osteoarthritis
por: Findlay, David M., et al.
Publicado: (2014) -
Monocyte Chemoattractant Protein-1 (MCP-1/CCL2) Drives Activation of Bone Remodelling and Skeletal Metastasis
por: Mulholland, Bridie S., et al.
Publicado: (2019) -
Epigenetic Regulators of Mesenchymal Stem/Stromal Cell Lineage Determination
por: Cakouros, Dimitrios, et al.
Publicado: (2020) -
Growth/differentiation factor 15 causes TGFβ-activated kinase 1-dependent muscle atrophy in pulmonary arterial hypertension
por: Garfield, Benjamin E, et al.
Publicado: (2019) -
Carbohydrate supplementation during prolonged cycling exercise spares muscle glycogen but does not affect intramyocellular lipid use
por: Stellingwerff, Trent, et al.
Publicado: (2007)